Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
FUSN

FUSN - Fusion Pharmaceuticals Inc Stock Price, Fair Value and News

$21.55 
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

FUSN Price Action

FUSN RSI Chart

FUSN Valuation

FUSN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

FUSN Fundamentals

FUSN Revenue

FUSN Earnings

FUSN Profitability

FUSN Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202411.1M000
20234.0M6.3M8.5M9.5M
2022826.0K1.3M1.7M2.2M
2021000381.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About Fusion Pharmaceuticals Inc

FUSN
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines in Canada and the United States. Its lead product candidates include FPI-2265 that is in Phase 2 clinical trial to treat prostate-specific membrane antigens; and FPI-1434 that is in Phase 1 clinical trial as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. The company also conducting additional preclinical studies of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors to further assess the anti-tumor activity, and dosing schedule and pharmacodynamics of the combinations. In addition, it develops FPI-1966 for the treatment of multiple cancers, including colorectal, ovarian, bladder, and head and neck cancers. The company has a strategic collaboration agreement with AstraZeneca UK Limited to discover, develop, and commercialize alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada.
 CEO
 WEBSITEhttps://fusionpharma.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES101